Dr. David A. Braun sat down for an interview with CURE® to discuss a study, on which he is a co-author, and delved into the molecular factors which drive exceptional responses to immunotherapy in metastatic clear cell renal cell carcinoma (ccRCC), a type …

… and reliability in treating localized tumors and … innovation in medical treatments that require pinpoint … Liver Cancer • Breast Cancer • Kidney Cancer • Prostate Cancer • Cardiac … Developments • January 2025: IceCure Medical Ltd (ICCM) received FDA …

Neoadjuvant systemic treatment strategies have improved outcomes in … are urgently needed for the development of adaptive perioperative immunotherapy strategies … Medicine, New Haven, CT, USA., Kidney Cancer Program, Simmons Comprehensive Cancer Center …

… of drug resistance compromises the effectiveness of the treatment. … considerable proportion of patients develop salivary gland dysfunction … cancer, sarcoma, and kidney cancer appeared with very low … clinical trial and fMRI study. BMC Complement Med Ther. …

… absence of effective pharmacologic agents to prevent … and difficult to fully treat. Furthermore, obesity … advancing the development of personalized treatment strategies. The … Gallstones, cholecystectomy, and kidney cancer: observational and Mendelian …

… advancements and industrial development following the Industrial … result in delayed cancer treatments, medication shortages, and increased … procedures needed to treat chronic urological conditions. … intake (linked to kidney cancer risk), increasing plant …

… the realm of oncology. Recent developments in kidney cancer biopsy procedures, led by … at the forefront of kidney cancer diagnostics and treatment methodologies. The optical coherence … sector to closely follow these developments. The integration of enhanced …

… technique is widely used for treating liver, kidney, lung, … procedures has expanded to treat cancers of the liver, … on Application •Liver Cancer •Kidney Cancer •Lung Cancer •Breast Cancer … and development in this area hold promise for enhancing treatment …

General Surgery Device Market LAS VEGAS, NV, UNITED STATES, January 29, 2025 /⁨EINPresswire.com⁩/ -- The Global General Surgery Device Market is estimated to grow at a CAGR of 5.89% during the forecast period from 2024 to 2030. The demand for …

The introduction of vascular endothelial growth factor receptor-tyrosine kinases (VEGFR-TKIs) and immune checkpoint inhibitors (IOs) have drastically altered the treatment landscape for kidney cancer, with doublet combination immunotherapy (IO/IO or IO …